{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:37:16Z","timestamp":1777592236381,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,9,14]],"date-time":"2013-09-14T00:00:00Z","timestamp":1379116800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00726-013-1533-x","type":"journal-article","created":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T04:59:02Z","timestamp":1379048342000},"page":"311-319","source":"Crossref","is-referenced-by-count":31,"title":["Detection of diabetic nephropathy from advanced glycation endproducts (AGEs) differs in plasma and urine, and is dependent on the method of preparation"],"prefix":"10.1007","volume":"46","author":[{"given":"Paul J.","family":"Beisswenger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott K.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen S.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Mauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,14]]},"reference":[{"key":"1533_CR1","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/s00125-005-1810-7","volume":"48","author":"N Ahmed","year":"2005","unstructured":"Ahmed N, Babaei-Jadidi R, Howell S, Beisswenger P, Thornalley P (2005a) Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes. Diabetologia 48:1590\u20131603","journal-title":"Diabetologia"},{"key":"1533_CR2","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.2337\/diacare.28.10.2465","volume":"28","author":"N Ahmed","year":"2005","unstructured":"Ahmed N, Babaei-Jadidi R, Howell S, Thornalley P, Beisswenger P (2005b) Glycated and oxidised protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes. Diabetes Care 28:2465\u20132471","journal-title":"Diabetes Care"},{"issue":"6","key":"1533_CR3","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/BF00284458","volume":"25","author":"AR Andersen","year":"1983","unstructured":"Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T (1983) Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25(6):496\u2013501","journal-title":"Diabetologia"},{"key":"1533_CR4","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00726-010-0784-z","volume":"42","author":"P Beisswenger","year":"2012","unstructured":"Beisswenger P (2012) Glycation and biomarkers of vascular complications of diabetes. Amino Acids Glycation 42:1171\u20131183","journal-title":"Amino Acids Glycation"},{"key":"1533_CR5","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2337\/diacare.24.4.726","volume":"24","author":"P Beisswenger","year":"2001","unstructured":"Beisswenger P, Howell S, O\u2019Dell R, Wood M, Touchette A, Szwergold B (2001) Alpha dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia. Diabetes Care 24:726\u2013732","journal-title":"Diabetes Care"},{"key":"1533_CR6","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.2337\/diabetes.54.11.3274","volume":"54","author":"P Beisswenger","year":"2005","unstructured":"Beisswenger P, Drummond K, Nelson R, Howell S, Szwergold B, Mauer M (2005) Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress. Diabetes 54:3274\u20133281","journal-title":"Diabetes"},{"issue":"Suppl1","key":"1533_CR7","first-page":"S24","volume":"51","author":"P Beisswenger","year":"2008","unstructured":"Beisswenger P, Howell S, Szwergold B, Rich S, Russell G, Kim Y, Mauer M (2008) Progression of diabetic nephropathy is predicted by increased oxidative stress and decreased deglycation. Diabetologia 51(Suppl1):S24","journal-title":"Diabetologia"},{"issue":"6","key":"1533_CR8","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"M Brownlee","year":"2005","unstructured":"Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54(6):1615\u20131625","journal-title":"Diabetes"},{"issue":"9","key":"1533_CR9","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2337\/diabetes.49.9.1399","volume":"49","author":"ML Caramori","year":"2000","unstructured":"Caramori ML, Fioretto P, Mauer M (2000) The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? [Review] [91 refs]. Diabetes 49(9):1399\u20131408","journal-title":"Diabetes"},{"issue":"2","key":"1533_CR10","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2337\/diabetes.51.2.506","volume":"51","author":"ML Caramori","year":"2002","unstructured":"Caramori ML, Kim Y, Huang C, Fish AJ, Rich SS, Miller ME, Russell G, Mauer M (2002) Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. [Erratum appears in diabetes 2002 Apr; 51(4):1294]. Diabetes 51(2):506\u2013513","journal-title":"Diabetes"},{"issue":"24","key":"1533_CR11","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1056\/NEJMe0803831","volume":"358","author":"WT Cefalu","year":"2008","unstructured":"Cefalu WT (2008) Glycemic targets and cardiovascular disease. N Engl J Med 358(24):2633\u20132635","journal-title":"N Engl J Med"},{"issue":"19","key":"1533_CR12","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1001\/archinte.164.19.2090","volume":"164","author":"A Ceriello","year":"2004","unstructured":"Ceriello A, Hanefeld M, Leiter L, Monnier L, Moses A, Owens D, Tajima N, Tuomilehto J (2004) Postprandial glucose regulation and diabetic complications. [Review] [58 refs]. Arch Intern Med 164(19):2090\u20132095","journal-title":"Arch Intern Med"},{"issue":"14","key":"1533_CR13","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"DCCT Research Group","year":"1993","unstructured":"DCCT Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 329(14):977\u2013986","journal-title":"N Eng J Med"},{"key":"1533_CR14","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2337\/diab.46.11.1829","volume":"46","author":"DCCT Research Group","year":"1997","unstructured":"DCCT Research Group (1997) Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes 46:1829\u20131839","journal-title":"Diabetes"},{"issue":"19","key":"1533_CR15","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1001\/jama.287.19.2563","volume":"287","author":"DCCT\/EDIC Complications Research Group","year":"2002","unstructured":"DCCT\/EDIC Complications Research Group (2002) Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. Jama 287(19):2563\u20132569","journal-title":"Jama"},{"issue":"24","key":"1533_CR16","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1056\/NEJMe0804182","volume":"358","author":"RG Dluhy","year":"2008","unstructured":"Dluhy RG, McMahon GT (2008) Intensive glycemic control in the ACCORD and ADVANCE trials. N Engl J Med 358(24):2630\u20132633","journal-title":"N Engl J Med"},{"key":"1533_CR17","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/clinchem\/33.9.1656","volume":"339","author":"H Drexel","year":"1987","unstructured":"Drexel H, Klocker H, Patsch JR, Breier C, Braunsteiner H (1987) Measurement of glycated protein by a rapid and specific method for absolute quantification of lysine-bound glucose. Clin Chem 339:1656\u20131659","journal-title":"Clin Chem"},{"issue":"5","key":"1533_CR18","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.2337\/diabetes.51.5.1580","volume":"51","author":"K Drummond","year":"2002","unstructured":"Drummond K, Mauer M, International Diabetic Nephropathy Study Group (2002) The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes 51(5):1580\u20131587","journal-title":"Diabetes"},{"issue":"7","key":"1533_CR19","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.2337\/diabetes.52.7.1818","volume":"52","author":"KN Drummond","year":"2003","unstructured":"Drummond KN, Kramer MS, Suissa S, Levy-Marchal C, Dell\u2019Aniello S, Sinaiko A, Mauer M, G. International Diabetic Nephropathy Study (2003) Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy. Diabetes 52(7):1818\u20131824","journal-title":"Diabetes"},{"issue":"11","key":"1533_CR20","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.2337\/diab.43.11.1358","volume":"43","author":"P Fioretto","year":"1994","unstructured":"Fioretto P, Steffes MW, Mauer M (1994) Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes 43(11):1358\u20131364","journal-title":"Diabetes"},{"issue":"4","key":"1533_CR21","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2337\/diabetes.48.4.865","volume":"48","author":"P Fioretto","year":"1999","unstructured":"Fioretto P, Steffes MW, Barbosa J, Rich SS, Miller ME, Mauer M (1999) Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs. Diabetes 48(4):865\u2013869","journal-title":"Diabetes"},{"issue":"6968","key":"1533_CR22","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nature02263","volume":"426","author":"AL Goldberg","year":"2003","unstructured":"Goldberg AL (2003) Protein degradation and protection against misfolded or damaged proteins. [Review] [45 refs]. Nature 426(6968):895\u2013899","journal-title":"Nature"},{"key":"1533_CR23","first-page":"267","volume":"18","author":"AJ Krolewski","year":"1987","unstructured":"Krolewski AJ, Warram JH, Kahn R, Kahn LI, Kahn CR (1987) Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Eng J Med 18:267\u2013273","journal-title":"N Eng J Med"},{"key":"1533_CR24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1006\/abio.1996.0454","volume":"242","author":"D Malencik","year":"1996","unstructured":"Malencik D, Sprouse J, Swanson C, Anderson S (1996) Dityrosine: preparation, isolation, and analysis. Anal Biochem 242:202\u2013213","journal-title":"Anal Biochem"},{"issue":"1","key":"1533_CR25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa0808400","volume":"361","author":"M Mauer","year":"2009","unstructured":"Mauer M, Zinman B, Gardiner R, Suissa S, Sinaiko A, Strand T, Drummond K, Donnelly S, Goodyer P, Gubler MC, Klein R (2009) Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med 361(1):40\u201351","journal-title":"N Engl J Med"},{"key":"1533_CR26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJM198407123110204","volume":"311","author":"CE Mogensen","year":"1984","unstructured":"Mogensen CE, Christensen C (1984) Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89\u201393","journal-title":"N Engl J Med"},{"key":"1533_CR27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4158\/EP.12.S1.42","volume":"1","author":"L Monnier","year":"2006","unstructured":"Monnier L, Colette C (2006) Contributions of fasting and postprandial glucose to hemoglobin A1c. [Review] [20 refs]. Endocr Pract 1:42\u201346","journal-title":"Endocr Pract"},{"key":"1533_CR28","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1196\/annals.1333.065","volume":"1043","author":"VM Monnier","year":"2005","unstructured":"Monnier VM, Sell DR, Genuth S (2005) Glycation products as markers and predictors of the progression of diabetic complications. [Review] [78 refs]. Ann N Y Acad Sci 1043:567\u2013581","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1533_CR29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MNH.0b013e3283293db1","volume":"18","author":"BA Perkins","year":"2009","unstructured":"Perkins BA, Krolewski AS (2009) Early nephropathy in type 1 diabetes: the importance of early renal function decline. Curr Opin Nephrol Hypertens 18(3):233\u2013240","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"7","key":"1533_CR30","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/BF00404096","volume":"33","author":"D Pettitt","year":"1990","unstructured":"Pettitt D, Saad M, Bennett P, Nelson R, Knowler W (1990) Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 33(7):438\u2013443","journal-title":"Diabetologia"},{"key":"1533_CR31","first-page":"854","volume":"21","author":"TC Prager","year":"1981","unstructured":"Prager TC, Wilson DJ, Avery GD (1981) Vitreous fluorophotometry: identification of sources of variability. Invest Ophthalmol Vis Sci 21:854\u2013864","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"1533_CR32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2337\/diacare.25.2.275","volume":"25","author":"CL Rohlfing","year":"2002","unstructured":"Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE (2002) Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the diabetes control and complications trial. Diabetes Care 25(2):275\u2013278","journal-title":"Diabetes Care"},{"key":"1533_CR33","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1042\/bj0420485","volume":"42","author":"J Roper","year":"1948","unstructured":"Roper J, McIlwain H (1948) Preparation and antibacterial action of some compounds structurally related to glutamic acid their applications in microbiological determinations of small quantities of glutamine. Biochem J 42:485\u2013492","journal-title":"Biochem J"},{"key":"1533_CR34","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJM198905043201801","volume":"320","author":"ER Seaquist","year":"1989","unstructured":"Seaquist ER, Goetz FC, Rich S, Barbosa J (1989) Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161\u20131165","journal-title":"N Engl J Med"},{"issue":"7","key":"1533_CR35","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.2337\/diabetes.54.7.2164","volume":"54","author":"JM Steinke","year":"2005","unstructured":"Steinke JM, Sinaiko AR, Kramer MS, Suissa S, Chavers BM, Mauer M (2005) The early natural history of nephropathy in type 1 diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes 54(7):2164\u20132171","journal-title":"Diabetes"},{"issue":"Pt 3","key":"1533_CR36","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/bj20030763","volume":"375","author":"PJ Thornalley","year":"2003","unstructured":"Thornalley PJ, Battah S, Ahmed N, Karachalias N, Agalou S, Babaei-Jadidi R, Dawnay A (2003) Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J 375(Pt 3):581\u2013592","journal-title":"Biochem J"},{"issue":"21","key":"1533_CR37","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","volume":"281","author":"RC Turner","year":"1999","unstructured":"Turner RC, Cull CA, Frighi V, Holman RR (1999) Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 281(21):2005\u20132012","journal-title":"JAMA"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-013-1533-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00726-013-1533-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-013-1533-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:10:19Z","timestamp":1596499819000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00726-013-1533-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,14]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["1533"],"URL":"https:\/\/doi.org\/10.1007\/s00726-013-1533-x","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,14]]}}}